Diagnosis and Management of Clostridium difficile Infection by Pediatric Infectious Diseases Physicians | Zendy

Julia Shaklee Sammons | Zendy; Jeffrey S. Gerber | Zendy; Pranita D. Tamma | Zendy; Thomas J. Sandora | Zendy; Susan E. Beekmann | Zendy; Philip M. Polgreen | Zendy; Adam L. Hersh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diagnosis and Management of Clostridium difficile Infection by Pediatric Infectious Diseases Physicians

Author(s) -

Julia Shaklee Sammons,

Jeffrey S. Gerber,

Pranita D. Tamma,

Thomas J. Sandora,

Susan E. Beekmann,

Philip M. Polgreen,

Adam L. Hersh

Publication year - 2013

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pit065

Subject(s) - medicine , fidaxomicin , clostridium difficile , metronidazole , incidence (geometry) , vancomycin , disease , pediatrics , intensive care medicine , infectious disease (medical specialty) , population , antibiotics , staphylococcus aureus , physics , optics , environmental health , biology , bacteria , microbiology and biotechnology , genetics

The incidence of C difficile infection (CDI) has risen among children; however, optimal management of CDI within a diverse pediatric population remains unclear. Although adult guidelines recommend oral vancomycin for treatment of second recurrence or severe CDI, dedicated pediatric data to support pediatric specific management guidelines are lacking. Our objective was to describe current CDI management practices by pediatric infectious diseases (ID) physicians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research